LISURIDE, A DOPAMINE AGONIST IN THE TREATMENT OF EARLY PARKINSONS-DISEASE

被引：125

作者：

RINNE, UK

机构：

来源：

NEUROLOGY | 1989年 / 39卷 / 03期

关键词：

D O I：

10.1212/WNL.39.3.336

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：336 / 339

页数：4

共 23 条

[1]

BIRKMAYER W, 1976, ADV PARKINSONISM, P407

[2]

Carlsson A, 1983, J Neural Transm Suppl, V19, P153

[3]

DUVOISIN RC, 1971, MONOAMINES NOYAUX GR, P313

[4]

GESSA GL, 1988, J NEURAL TRANSM-SUPP, V7, P201

[5] A POSSIBLE MOLECULAR MECHANISM FOR THE ANTIPARKINSONIAN ACTION OF BROMOCRIPTINE IN COMBINATION WITH LEVODOPA [J].

GOLDSTEIN, M ;

LIEBERMAN, A ;

MELLER, E .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1985, 6 (11) :436-437

[6]

HOROWSKI R, 1979, DOPAMINERGIC ERGOT D, P237

[7] BRAIN DOPAMINE METABOLISM IN PATIENTS WITH PARKINSONS-DISEASE MEASURED WITH POSITRON EMISSION TOMOGRAPHY [J].

LEENDERS, KL ;

PALMER, AJ ;

QUINN, N ;

CLARK, JC ;

FIRNAU, G ;

GARNETT, ES ;

NAHMIAS, C ;

JONES, T ;

MARSDEN, CD .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1986, 49 (08) :853-860

[8] NEUROCHEMICAL EFFECTS OF SOME ERGOT DERIVATIVES - A BASIS FOR THEIR ANTI-PARKINSON ACTIONS [J].

MARKSTEIN, R .

JOURNAL OF NEURAL TRANSMISSION, 1981, 51 (1-2) :39-59

[9]

OGAWA N, 1984, Neurosciences, V10, P259

[10] LOW-DOSE L-DOPA THERAPY IN PARKINSONS-DISEASE - A 6-YEAR FOLLOW-UP-STUDY [J].

POEWE, WH ;

LEES, AJ ;

STERN, GM .

NEUROLOGY, 1986, 36 (11) :1528-1530

← 1 2 3 →